Demand for chip-design software is booming, making Synopsys the chip-design name to own after Cadence's results. Cadence reported a record $8.2 billion backlog and raised its 2026 revenue-growth outlook to 21%; Synopsys is still about 12% below its May high, and all four models signal Long on Synopsys versus Flat on Cadence. x.com 

Semiconductors look set to outperform software. Hedge funds are simultaneously the most overweight semis and most underweight software in a decade, and last year's compression in software valuations made that signal impossible to ignore. Within chips, photonics, memory and CPUs are the favored areas. x.com 

LLM-driven hardware verification is generally bearish for Synopsys and Cadence, but not predictably enough in the short term to justify betting against them. A post being answered argues verification is the cleanest monetization path for the new LLM capability, with private math pure plays Harmonic and Axiom Math likely to target it, so sentiment on both should worsen. The development is broadly bullish for compute. x.com 

Synopsys's investor day directly undercut the bear case, so the tepid stock reaction is hard to explain. It smashed 2027 revenue growth estimates and raised long-term targets for both segments. Its OpenAI partnership to jointly develop a model could look like letting the fox into the henhouse, but it is a direct admission that AI cannot bypass Synopsys's IP-protected data moat, which was the core bear argument. x.com 

Synopsys's OpenAI deal and investor day have blown up the bear case that frontier AI will disrupt chip-design software. When OpenAI has dominant leverage over a partner, as with Cerebras, it extracts big equity concessions; it did not with Synopsys. KeyBanc called the investor day perfectly executed, citing much better than expected initial FY27 guidance, higher long-term EDA and IP targets, margin expansion and new AWS and OpenAI partnerships, and raised its target while reiterating Overweight. … Show more

Synopsys and Cadence are shorts while ASIC design houses Global Unichip and Alchip are longs, because hyperscalers are taking chip IP design in-house. Synopsys design IP income fell 48% in Q1 to $66.1M, yet EDA trades near 70x earnings after losing China. Megacap seat counts are flat to down as AI makes engineers 2-3x more productive; Google TPU, AWS Trainium and other ASICs sold Cadence no new seats. Global Unichip revenue is up 60%, and Alchip, working on Trainium, is the highest-beta long. … Show more

Synopsys is the clear stand-alone way to play an Intel turnaround. The picture is less certain once Tesla's involvement with Intel is factored in, since Tesla uses Cadence. x.com 

Synopsys and Cadence benefit as AI shifts from general-purpose to specific-purpose models, a transition moving unusually fast and a sign this is a continuation of the buildout rather than a new cycle. Synopsys and OpenAI signed a multi-year deal to build GPT-Synopsys, a model that runs Synopsys EDA tools for tasks like timing closure and verification, with shared revenue. Synopsys also announced a multi-year, $1B+ silicon IP agreement with Amazon, showing what EDA players' IP can be used for. … Show more

Microsoft and Oracle are down and out because they are software businesses, and the market is rational to trade them like the software sector rather than like pure GPU scalers such as CoreWeave and Nebius, or Alphabet, a scaler without software exposure. Meta is an outlier with its own issues: secular uncertainty and no cash flow after capex. x.com  x.com 

Synopsys merits Overweight and a $650 December 2026 target because EDA's near-permanent switching costs give a durable recurring floor, while emulation and AI-enhanced tools lift growth and margins. Synopsys, Cadence and Siemens EDA control most of the market, and switching toolchains costs engineering years. AI chip design drives emulation hours, and ML tools command a pricing premium. The target is about 40x $16.20 of earnings power exiting 2H CY26; China export controls are the key risk. … Show more